By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Sanaria Inc. 

12115 Parklawn Drive
Suite L
Rockville  Maryland  20852  U.S.A.
Phone: 301-770-3222 Fax: 301-770-5554




Company News
Sanaria Inc.'s PfSPZ-CVac Vaccine Achieves High Level Protection Against Malaria In Clinical Trial 2/16/2017 8:06:29 AM
Sanaria Inc. Release: Pharma's PfSPZ Vaccine Provides High Level Defense Against Malaria In U.S. Navy And Army Clinical Investigation 1/12/2017 8:31:32 AM
Sanaria Inc. PfSPZ Vaccine Against Malaria Receives D&A Pharma Fast Track Designation 9/22/2016 7:57:53 AM
Sanaria Inc.'s Malaria Vaccine Yields Unprecedented Protection In Clinical Trial 5/9/2016 10:19:34 AM
CryoPort, Inc. And Sanaria Inc. Expand Logistics Partnership Supporting Malaria Vaccines 2/23/2015 7:11:46 AM
Sanaria Inc.'s Malaria Vaccine Impresses in Phase 1 Trial 8/9/2013 5:54:29 AM
Malaria Vaccine Developer Sanaria Inc.. and the Institute for Bioscience and Biotechnology Research of the University of Maryland College Park Awarded Collaborative, US $3M National Institutes of Health (NIH) Phase II Small Business Innovation Research Grant 6/14/2012 10:21:35 AM
Malaria Parasite and Mosquito Products and Assay Services Available for Sale by Sanaria Inc. 6/30/2011 5:58:55 AM
Sanaria Inc. Receives Multi-Year U.S. NIH Phase II Small Business Innovation Research Grant to Develop a Genetically Attenuated Whole Parasite Malaria Vaccine 2/23/2010 11:32:06 AM
Sanaria Inc. Release: Phase 1 Trial of Whole-Parasite Malaria Vaccine to Begin 4/23/2009 8:27:34 AM